Chapter

Viral platforms for expression of tumor antigens in cancer immunotherapy

Karishma Rajani, Vanessa Alonso-Camino, Nicolas Boisgerault and Richard Vile

in Tumor Immunology and Immunotherapy

Published on behalf of Oxford University Press

Published in print May 2014 | ISBN: 9780199676866
Published online July 2014 | e-ISBN: 9780191756245 | DOI: https://dx.doi.org/10.1093/med/9780199676866.003.0015
Viral platforms for expression of tumor antigens in cancer immunotherapy

More Like This

Show all results sharing these subjects:

  • Immunology
  • Radiation Oncology

GO

Show Summary Details

Preview

In the field of cancer virotherapy, many efforts are now focused on enhancing the immune response together with the direct lysis of tumor cells or inducement of apoptosis. One of the strategies that has emerged in this regard is the modification of viral vectors to encode for tumor-associated antigens (TAAs). The combination of viruses encoding TAAs with other approaches like the adoptive transfer of T cells, or the expression of multiple TAAs to target multiple epitopes, could also considerably improve the therapy and avoid tumor recurrence. This chapter focuses primarily on the recent advancements of adenovirus, poxvirus and vesicular stomatitis virus (VSV)-based preclinical studies, and clinical trials in tumour virotherapy.

Chapter.  7429 words.  Illustrated.

Subjects: Immunology ; Radiation Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.